Author:
Venderbos Lionne D. F.,Roobol Monique J.,Bangma Chris H.,van den Bergh Roderick C. N.,Bokhorst Leonard P.,Nieboer Daan,Godtman Rebecka,Hugosson Jonas,van der Kwast Theodorus,Steyerberg Ewout W.
Funder
Europe Against Cancer
the fifth and sixth framework program of the European Union
unconditional grants from Beckman- Coulter-Hybritech Inc
ERSPC Rotterdam - Dutch Cancer Society, the Netherlands organization for health and research development, the Abe Bonnema foundation
ERSPC Sweden - Abbott Pharmaceuticals, Sweden, Af Jochnick’s foundation, Catarina and Sven Hagstroms family foundation, Gunvor and Ivan Svensson’s foundation, Johanniterorden, King Gustav V Jubilée Clinic Cancer Research Foundation, Sahlgrenska University Hospital, Schering Plough, Sweden, Swedish Cancer Society, Wallac Oy, Turku, Finland
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Bangma CH, Roobol MJ, Steyerberg EW (2009) Predictive models in diagnosing indolent cancer. Cancer 115(13 Suppl):3100–3106
2. van den Bergh RC, Roemeling S, Roobol MJ, Roobol W, Schroder FH, Bangma CH (2007) Prospective validation of active surveillance in prostate cancer: the PRIAS study. Eur Urol 52(6):1560–1563
3. Ip S, Dahabreh IJ, Chung M et al (2011) An evidence review of active surveillance in men with localized prostate cancer. Evid Rep Technol Assess (Full Rep). 204:1–341
4. Venderbos LD, Bokhorst LP, Bangma CH, Roobol MJ (2013) Active surveillance: oncologic outcome. Curr Opin Urol 23(3):268–272
5. Bul M, van den Bergh RC, Rannikko A et al (2012) Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program. Eur Urol 61(2):370–377 (Epub 2011/06/28)
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献